Dare Bioscience, Inc.
DARE· Nasdaq
Filed May 6, 2015 · 10-Q · 36 days after period end · 0001564590-15-003416
| Metric | Q1 2015 | Q1 2014 | Q1 2013 |
|---|---|---|---|
| Revenue | $0.00 | $47.00K | — |
| Net Income | -$8.42M | -$2.91M | -$5.57M |
| EPS Diluted | -$0.41 | -$3.70 | -$9.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Dare Bioscience, Inc. · CIK 1401914 · Engraved from SEC EDGAR
ended Mar 31, 2015 · filed May 6, 2015 · 36 d after period end